BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 20567777)

  • 1. Conformational degeneracy restricts the effective information content of heparan sulfate.
    Rudd TR; Yates EA
    Mol Biosyst; 2010 May; 6(5):902-8. PubMed ID: 20567777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparable stabilisation, structural changes and activities can be induced in FGF by a variety of HS and non-GAG analogues: implications for sequence-activity relationships.
    Rudd TR; Uniewicz KA; Ori A; Guimond SE; Skidmore MA; Gaudesi D; Xu R; Turnbull JE; Guerrini M; Torri G; Siligardi G; Wilkinson MC; Fernig DG; Yates EA
    Org Biomol Chem; 2010 Dec; 8(23):5390-7. PubMed ID: 20865198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural studies of heparan sulfate hexasaccharides: new insights into iduronate conformational behavior.
    Murphy KJ; McLay N; Pye DA
    J Am Chem Soc; 2008 Sep; 130(37):12435-44. PubMed ID: 18722428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A conformational change in heparan sulfate 3-O-sulfotransferase-1 is induced by binding to heparan sulfate.
    Edavettal SC; Carrick K; Shah RR; Pedersen LC; Tropsha A; Pope RM; Liu J
    Biochemistry; 2004 Apr; 43(16):4680-8. PubMed ID: 15096036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 13C-labeled heparan sulfate analogue as a tool to study protein/heparan sulfate interactions by NMR spectroscopy: application to the CXCL12α chemokine.
    Laguri C; Sapay N; Simorre JP; Brutscher B; Imberty A; Gans P; Lortat-Jacob H
    J Am Chem Soc; 2011 Jun; 133(25):9642-5. PubMed ID: 21634378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heparin and heparan sulfate biosynthesis.
    Sugahara K; Kitagawa H
    IUBMB Life; 2002 Oct; 54(4):163-75. PubMed ID: 12512855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conformation and dynamics of heparin and heparan sulfate.
    Mulloy B; Forster MJ
    Glycobiology; 2000 Nov; 10(11):1147-56. PubMed ID: 11087707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design of biologically active heparan sulfate and heparin using an enzyme-based approach.
    Peterson S; Frick A; Liu J
    Nat Prod Rep; 2009 May; 26(5):610-27. PubMed ID: 19387498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of the mouse mastocytoma glucosaminyl N-deacetylase/ N-sulfotransferase in human kidney 293 cells results in increased N-sulfation of heparan sulfate.
    Cheung WF; Eriksson I; Kusche-Gullberg M; Lindhal U; Kjellén L
    Biochemistry; 1996 Apr; 35(16):5250-6. PubMed ID: 8611511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biosynthesis of 3-O-sulfated heparan sulfate: unique substrate specificity of heparan sulfate 3-O-sulfotransferase isoform 5.
    Chen J; Duncan MB; Carrick K; Pope RM; Liu J
    Glycobiology; 2003 Nov; 13(11):785-94. PubMed ID: 12907690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinct effects on heparan sulfate structure by different active site mutations in NDST-1.
    Bengtsson J; Eriksson I; Kjellén L
    Biochemistry; 2003 Feb; 42(7):2110-5. PubMed ID: 12590599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. (1)H nuclear magnetic resonance spectroscopic analysis for determination of glucuronic and iduronic acids in dermatan sulfate, heparin, and heparan sulfate.
    Sudo M; Sato K; Chaidedgumjorn A; Toyoda H; Toida T; Imanari T
    Anal Biochem; 2001 Oct; 297(1):42-51. PubMed ID: 11567526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Using NMR to Dissect the Chemical Space and
    Meneghetti MCZ; Naughton L; O'Shea C; Koffi Teki DS; Chagnault V; Nader HB; Rudd TR; Yates EA; Kovensky J; Miller GJ; Lima MA
    ACS Omega; 2022 Jul; 7(28):24461-24467. PubMed ID: 35874203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of the N-deacetylase domain from the heparan sulfate N-deacetylase/N-sulfotransferase 2.
    Duncan MB; Liu M; Fox C; Liu J
    Biochem Biophys Res Commun; 2006 Jan; 339(4):1232-7. PubMed ID: 16343444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Active conformations of glycosaminoglycans. NMR determination of the conformation of heparin sequences complexed with antithrombin and fibroblast growth factors in solution.
    Hricovíni M; Guerrini M; Bisio A; Torri G; Naggi A; Casu B
    Semin Thromb Hemost; 2002 Aug; 28(4):325-34. PubMed ID: 12244479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibody-based assay for N-deacetylase activity of heparan sulfate/heparin N-deacetylase/N-sulfotransferase (NDST): novel characteristics of NDST-1 and -2.
    van den Born J; Pikas DS; Pisa BJ; Eriksson I; Kjellen L; Berden JH
    Glycobiology; 2003 Jan; 13(1):1-10. PubMed ID: 12634318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular organization and antiproliferative domains of arterial tissue heparan sulfate.
    Schmidt A; Lemming G; Yoshida K; Buddecke E
    Eur J Cell Biol; 1992 Dec; 59(2):322-8. PubMed ID: 1493797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tinkering with heparan sulfate sulfation to steer development.
    Gorsi B; Stringer SE
    Trends Cell Biol; 2007 Apr; 17(4):173-7. PubMed ID: 17320398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. (1)H and (15)N NMR Characterization of the Amine Groups of Heparan Sulfate Related Glucosamine Monosaccharides in Aqueous Solution.
    Beecher CN; Larive CK
    Anal Chem; 2015 Jul; 87(13):6842-8. PubMed ID: 26020565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of substitution pattern on 1H, 13C NMR chemical shifts and 1J(CH) coupling constants in heparin derivatives.
    Yates EA; Santini F; De Cristofano B; Payre N; Cosentino C; Guerrini M; Naggi A; Torri G; Hricovini M
    Carbohydr Res; 2000 Oct; 329(1):239-47. PubMed ID: 11086706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.